• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechansim

ABPI_Incentivising_Antibioics_peter-pryharski-unsplash_landscape
Read more

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 30th March 2010

PROMs and Choice in the NHS

PROMs are intended to fill a critical gap in understanding the impact of health care on the patient’s quality of life. OHE is closely involved in PROMs research and policy discussions. Health care accounts for a significant portion of economic…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
NHS Outcomes, Performance and Productivity

PROMs are intended to fill a critical gap in understanding the impact of health care on the patient’s quality of life. OHE is closely involved in PROMs research and policy discussions.

Health care accounts for a significant portion of economic activity in all medically advanced countries.  In the UK in 2007/8, for example, slightly more than 18% of government spending was on health care. Policy makers and taxpayers naturally want to know what value patients receive, i.e., whether the output is commensurate with the input.

Measuring productivity and value in health care is not easy.  Many once-deadly diseases have been transformed into chronic diseases, making measures of mortality very poor indicators of value for most diseases.  Clinical outcomes can offer a more nuanced set of measures, but also fall short in one important aspect: measuring the impact of health care on the patient’s overall quality of life, during and after diagnosis and/or treatment.

Measuring value in health care is a key focus of OHE’s work.  We are closely involved now in promoting and facilitating the routine use of patient-reported outcomes measures (PROMs) in health care.  A PROM is a series of questions about patients’ own assessments of their health and health-related quality of life. (They do not include questions about patients’ satisfaction or experience with health care services, or seek their opinions about the success of treatment.)

NHS Outcomes, Performance and Productivity OHE Commission Report

 

OHE began its contribution on PROMs with the OHE Commission on NHS Outcomes, Performance and Productivity.  The Commission included a panel of senior experts in economics, medicine, epidemiology, management and policy — and the viewpoints of the  public and private health care sectors, professionals, patients and the general public. The purpose of the Commission was to review the evidence, commission research where necessary, and determine what patient outcomes data could and should be routinely collected and analysed by the NHS.

In its report, released in 2008, the Commission commended the Department of Health for including in its 2008/9 Framework requirements for PROMs for four types of surgical procedures.  It noted, however, that it was both practical and desirable for the NHS to go much further than, and soon.  The Commission concluded that processes for collecting PROMs data reasonably could be in place within five years for the majority of NHS activities.  The report also offers recommendations about where to focus initially and what measures to emphasise.

OHE’s Continuing Involvement in PROMs

Continuing OHE involvement in PROMs is led by Prof Nancy Devlin, Director of Research at the OHE.  A summary of her recent publication with the King’s Fund will appear in a subsequent post and we will be reporting regularly on new developments.  Both Nancy Devlin and Adrian Towse are on the Department of Health’s PROMs stakeholder reference group and are working with the DH to ensure the success of the groundbreaking PROMs programme introduced in the English NHS in 2009.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Commission

Related News

Report of OHE Commission on Competition in the NHS
  • News
  • October 2012

Competition in the NHS: Proceed with Care

Read more
Report of OHE Commission on Competition in the NHS
  • News
  • January 2012

Report: Competition Can Help the NHS – But Proceed with Care

Read more
Commission214_30Jan
  • News
  • February 2011

New OHE Commission on Competition in the NHS

Read more
Tony Atkinson
  • News
  • April 2010

Measuring Health Output, Productivity and Equity

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!